Chronic ephedrine administration decreases brown adipose tissue activity in a randomised controlled human trial: implications for obesity.

Carey, Andrew L; Pajtak, Renata; Formosa, Melissa F; Van Every, Bruce; Bertovic, David A; Anderson, Mitchell J; Eikelis, Nina; Lambert, Gavin W; Kalff, Victor; Duffy, Stephen J; Cherk, Martin H; Kingwell, Bronwyn A

Carey, Andrew L; Pajtak, Renata; Formosa, Melissa F; Van Every, Bruce; Bertovic, David A; Anderson, Mitchell J; Eikelis, Nina; Lambert, Gavin W; Kalff, Victor; Duffy, Stephen J; Cherk, Martin H; Kingwell, Bronwyn A.

Affiliation

Carey AL; Metabolic and Vascular Physiology Laboratory, Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Road Central, Melbourne, VIC, 8008, Australia, andrew.carey@bakeridi.edu.au.

Diabetologia ; 58(5): 1045-54, 2015 May.

Article in En | MEDLINE | ID: mdl-25725625

Subject(s)

Adipose Tissue, Brown/drug effects; Body Composition/drug effects; Ephedrine/pharmacology; Sympathomimetics/pharmacology; Thermogenesis/drug effects; Adipose Tissue, Brown/diagnostic imaging; Adipose Tissue, Brown/metabolism; Blood Glucose; Blood Pressure/physiology; Ephedrine/therapeutic use; Fluorodeoxyglucose F18; Humans; Male; Obesity/drug therapy; Obesity/metabolism; Radionuclide Imaging; Sympathomimetics/therapeutic use; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Sympathomimetics / Body Composition / Adipose Tissue, Brown / Thermogenesis / Ephedrine Type of study: Clinical_trials Limits: Adult / Humans / Male Language: En Journal: Diabetologia Year: 2015 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google